Initially developed as a prognostic marker in oncology [8,9], HALP has subsequently demonstrated predictive value in other systemic conditions, including acute pancreatitis [10] and cardiovascular disease [29]. The gene discussed is NAT10; the disease is cardiovascular disorder.